While RIP1 is known to be critical for activation of NF-κB in melanoma cells13, we and others have previously shown that NF-κB is involved in intrinsic and acquired resistance of melanoma cells to BRAF inhibitors13, 20, 26–28. Here, NFKB1 is linked to melanoma.